Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Cetin

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Chemotherapy|February 3, 2018
Pazopanib-Induced Hepatotoxicity in an Experimental Rat ModelBulent Cetin, Guldal Esendagli Yılmaz, Berkan Armagan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 9, 2015
Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer PatientsOzge Gumusay, Bulent Cetin, Mustafa Benekli, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitorsBulent Cetin, Ipek Isık Gonul, Suleyman Buyukberber, et al.
Annals of Nuclear Medicine|October 2, 2014
Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary originEfnan Algin, Ahmet Ozet, Ozge Gumusay, et al.
Clinical Genitourinary Cancer|October 23, 2012
Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?Bulent Cetin, Veli Berk, Mehmet Ali Kaplan, et al.
Wiener Klinische Wochenschrift|March 16, 2016
Crizotinib-induced toxicity in an experimental rat modelOzge Gumusay, Guldal Esendagli-Yilmaz, Aytug Uner, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrenceOzge Gumusay, Bulent Cetin, Ahmet Ozet, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Nature|March 17, 2006
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis IChristian G Riedel, Vittorio L Katis, Yuki Katou, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Chemotherapy|February 3, 2018
Pazopanib-Induced Hepatotoxicity in an Experimental Rat ModelBulent Cetin, Guldal Esendagli Yılmaz, Berkan Armagan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 9, 2015
Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer PatientsOzge Gumusay, Bulent Cetin, Mustafa Benekli, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitorsBulent Cetin, Ipek Isık Gonul, Suleyman Buyukberber, et al.
Annals of Nuclear Medicine|October 2, 2014
Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary originEfnan Algin, Ahmet Ozet, Ozge Gumusay, et al.
Clinical Genitourinary Cancer|October 23, 2012
Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?Bulent Cetin, Veli Berk, Mehmet Ali Kaplan, et al.
Wiener Klinische Wochenschrift|March 16, 2016
Crizotinib-induced toxicity in an experimental rat modelOzge Gumusay, Guldal Esendagli-Yilmaz, Aytug Uner, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrenceOzge Gumusay, Bulent Cetin, Ahmet Ozet, et al.
Breast Care (Basel, Switzerland)|April 10, 2014
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) ExperienceBulent Cetin, Mustafa Benekli, Faysal Dane, et al.
Journal of Chemotherapy (Florence, Italy)|October 12, 2013
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)Bulent Cetin, Mustafa Benekli, Ibrahim Turker, et al.
Nature|March 17, 2006
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis IChristian G Riedel, Vittorio L Katis, Yuki Katou, et al.
Pageof 8